Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 890, pseudogene (ZNF890P) is classified as a pseudogene in the human genome. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they typically arise from gene duplication or retrotransposition events followed by mutations that prevent expression or function. ZNF890P is homologous to zinc finger proteins, which are structural motifs involved in DNA, RNA, protein, or small molecule binding, but this pseudogene does not produce a protein and currently has no known biological function, disease relevance, or utility as a therapeutic target. There is no evidence of protein expression, biological activity, or clinical significance for ZNF890P according to current genome databases and gene registry authorities.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 890, pseudogene (ZNF890P).